Quantification of the spatial distribution of rectally applied surrogates for microbicide and semen in colon with SPECT and magnetic resonance imaging

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Rectally applied drugs have been imaged using radioisotopes and magnetic resonance contrast agents. However, prior studies have not described the distribution and clearance of rectally‐applied drugs in quantitative terms with respect to complex three dimens...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of clinical pharmacology Vol. 74; no. 6; pp. 1013 - 1022
Main Authors Cao, Ying J., Caffo, Brian S., Fuchs, Edward J., Lee, Linda A., Du, Yong, Li, Liye, Bakshi, Rahul P., Macura, Katarzyna, Khan, Wasif A., Wahl, Richard L., Grohskopf, Lisa A., Hendrix, Craig W.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.12.2012
Blackwell Science Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Rectally applied drugs have been imaged using radioisotopes and magnetic resonance contrast agents. However, prior studies have not described the distribution and clearance of rectally‐applied drugs in quantitative terms with respect to complex three dimensional paths through the gastrointestinal tract. Such tools would allow statistical comparisons of candidate products in development or comparison of drug product with the distribution of a drug target, for example, HIV infected seminal fluid. WHAT THIS STUDY ADDS • New quantitative spatial parameters, derived from three dimensional curve fitting, have been successfully applied in this study to quantify the distribution of rectally‐applied gels. Indirect assessment using nuclear medicine techniques avoided the distortion and redistribution associated with sigmoidoscopic sampling. Thus, these measurements can be repeated over time to create concentration–distance–time surfaces to describe rectal product distribution and clearance within the gastrointestinal lumen to inform microbicide and other rectal product development. AIMS We sought to describe quantitatively the distribution of rectally administered gels and seminal fluid surrogates using novel concentration–distance parameters that could be repeated over time. These methods are needed to develop rationally rectal microbicides to target and prevent HIV infection. METHODS Eight subjects were dosed rectally with radiolabelled and gadolinium‐labelled gels to simulate microbicide gel and seminal fluid. Rectal doses were given with and without simulated receptive anal intercourse. Twenty‐four hour distribution was assessed with indirect single photon emission computed tomography (SPECT)/computed tomography (CT) and magnetic resonance imaging (MRI), and direct assessment via sigmoidoscopic brushes. Concentration–distance curves were generated using an algorithm for fitting SPECT data in three dimensions. Three novel concentration–distance parameters were defined to describe quantitatively the distribution of radiolabels: maximal distance (Dmax), distance at maximal concentration (DCmax) and mean residence distance (Dave). RESULTS The SPECT/CT distribution of microbicide and semen surrogates was similar. Between 1 h and 24 h post dose, the surrogates migrated retrograde in all three parameters (relative to coccygeal level; geometric mean [95% confidence interval]): maximal distance (Dmax), 10 cm (8.6–12) to 18 cm (13–26), distance at maximal concentration (DCmax), 3.8 cm (2.7–5.3) to 4.2 cm (2.8–6.3) and mean residence distance (Dave), 4.3 cm (3.5–5.1) to 7.6 cm (5.3–11). Sigmoidoscopy and MRI correlated only roughly with SPECT/CT. CONCLUSIONS Rectal microbicide surrogates migrated retrograde during the 24 h following dosing. Spatial kinetic parameters estimated using three dimensional curve fitting of distribution data should prove useful for evaluating rectal formulations of drugs for HIV prevention and other indications.
AbstractList WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Rectally applied drugs have been imaged using radioisotopes and magnetic resonance contrast agents. However, prior studies have not described the distribution and clearance of rectally‐applied drugs in quantitative terms with respect to complex three dimensional paths through the gastrointestinal tract. Such tools would allow statistical comparisons of candidate products in development or comparison of drug product with the distribution of a drug target, for example, HIV infected seminal fluid. WHAT THIS STUDY ADDS • New quantitative spatial parameters, derived from three dimensional curve fitting, have been successfully applied in this study to quantify the distribution of rectally‐applied gels. Indirect assessment using nuclear medicine techniques avoided the distortion and redistribution associated with sigmoidoscopic sampling. Thus, these measurements can be repeated over time to create concentration–distance–time surfaces to describe rectal product distribution and clearance within the gastrointestinal lumen to inform microbicide and other rectal product development. AIMS We sought to describe quantitatively the distribution of rectally administered gels and seminal fluid surrogates using novel concentration–distance parameters that could be repeated over time. These methods are needed to develop rationally rectal microbicides to target and prevent HIV infection. METHODS Eight subjects were dosed rectally with radiolabelled and gadolinium‐labelled gels to simulate microbicide gel and seminal fluid. Rectal doses were given with and without simulated receptive anal intercourse. Twenty‐four hour distribution was assessed with indirect single photon emission computed tomography (SPECT)/computed tomography (CT) and magnetic resonance imaging (MRI), and direct assessment via sigmoidoscopic brushes. Concentration–distance curves were generated using an algorithm for fitting SPECT data in three dimensions. Three novel concentration–distance parameters were defined to describe quantitatively the distribution of radiolabels: maximal distance (D max ), distance at maximal concentration (D C max ) and mean residence distance (D ave ). RESULTS The SPECT/CT distribution of microbicide and semen surrogates was similar. Between 1 h and 24 h post dose, the surrogates migrated retrograde in all three parameters (relative to coccygeal level; geometric mean [95% confidence interval]): maximal distance (D max ), 10 cm (8.6–12) to 18 cm (13–26), distance at maximal concentration (D C max ), 3.8 cm (2.7–5.3) to 4.2 cm (2.8–6.3) and mean residence distance (D ave ), 4.3 cm (3.5–5.1) to 7.6 cm (5.3–11). Sigmoidoscopy and MRI correlated only roughly with SPECT/CT. CONCLUSIONS Rectal microbicide surrogates migrated retrograde during the 24 h following dosing. Spatial kinetic parameters estimated using three dimensional curve fitting of distribution data should prove useful for evaluating rectal formulations of drugs for HIV prevention and other indications.
We sought to describe quantitatively the distribution of rectally administered gels and seminal fluid surrogates using novel concentration-distance parameters that could be repeated over time. These methods are needed to develop rationally rectal microbicides to target and prevent HIV infection.AIMSWe sought to describe quantitatively the distribution of rectally administered gels and seminal fluid surrogates using novel concentration-distance parameters that could be repeated over time. These methods are needed to develop rationally rectal microbicides to target and prevent HIV infection.Eight subjects were dosed rectally with radiolabelled and gadolinium-labelled gels to simulate microbicide gel and seminal fluid. Rectal doses were given with and without simulated receptive anal intercourse. Twenty-four hour distribution was assessed with indirect single photon emission computed tomography (SPECT)/computed tomography (CT) and magnetic resonance imaging (MRI), and direct assessment via sigmoidoscopic brushes. Concentration-distance curves were generated using an algorithm for fitting SPECT data in three dimensions. Three novel concentration-distance parameters were defined to describe quantitatively the distribution of radiolabels: maximal distance (D(max) ), distance at maximal concentration (D(Cmax) ) and mean residence distance (D(ave) ).METHODSEight subjects were dosed rectally with radiolabelled and gadolinium-labelled gels to simulate microbicide gel and seminal fluid. Rectal doses were given with and without simulated receptive anal intercourse. Twenty-four hour distribution was assessed with indirect single photon emission computed tomography (SPECT)/computed tomography (CT) and magnetic resonance imaging (MRI), and direct assessment via sigmoidoscopic brushes. Concentration-distance curves were generated using an algorithm for fitting SPECT data in three dimensions. Three novel concentration-distance parameters were defined to describe quantitatively the distribution of radiolabels: maximal distance (D(max) ), distance at maximal concentration (D(Cmax) ) and mean residence distance (D(ave) ).The SPECT/CT distribution of microbicide and semen surrogates was similar. Between 1 h and 24 h post dose, the surrogates migrated retrograde in all three parameters (relative to coccygeal level; geometric mean [95% confidence interval]): maximal distance (D(max) ), 10 cm (8.6-12) to 18 cm (13-26), distance at maximal concentration (D(Cmax) ), 3.8 cm (2.7-5.3) to 4.2 cm (2.8-6.3) and mean residence distance (D(ave) ), 4.3 cm (3.5-5.1) to 7.6 cm (5.3-11). Sigmoidoscopy and MRI correlated only roughly with SPECT/CT.RESULTSThe SPECT/CT distribution of microbicide and semen surrogates was similar. Between 1 h and 24 h post dose, the surrogates migrated retrograde in all three parameters (relative to coccygeal level; geometric mean [95% confidence interval]): maximal distance (D(max) ), 10 cm (8.6-12) to 18 cm (13-26), distance at maximal concentration (D(Cmax) ), 3.8 cm (2.7-5.3) to 4.2 cm (2.8-6.3) and mean residence distance (D(ave) ), 4.3 cm (3.5-5.1) to 7.6 cm (5.3-11). Sigmoidoscopy and MRI correlated only roughly with SPECT/CT.Rectal microbicide surrogates migrated retrograde during the 24 h following dosing. Spatial kinetic parameters estimated using three dimensional curve fitting of distribution data should prove useful for evaluating rectal formulations of drugs for HIV prevention and other indications.CONCLUSIONSRectal microbicide surrogates migrated retrograde during the 24 h following dosing. Spatial kinetic parameters estimated using three dimensional curve fitting of distribution data should prove useful for evaluating rectal formulations of drugs for HIV prevention and other indications.
times Rectally applied drugs have been imaged using radioisotopes and magnetic resonance contrast agents. However, prior studies have not described the distribution and clearance of rectally-applied drugs in quantitative terms with respect to complex three dimensional paths through the gastrointestinal tract. Such tools would allow statistical comparisons of candidate products in development or comparison of drug product with the distribution of a drug target, for example, HIV infected seminal fluid. WHAT THIS STUDY ADDS times New quantitative spatial parameters, derived from three dimensional curve fitting, have been successfully applied in this study to quantify the distribution of rectally-applied gels. Indirect assessment using nuclear medicine techniques avoided the distortion and redistribution associated with sigmoidoscopic sampling. Thus, these measurements can be repeated over time to create concentration-distance-time surfaces to describe rectal product distribution and clearance within the gastrointestinal lumen to inform microbicide and other rectal product development. AIMS We sought to describe quantitatively the distribution of rectally administered gels and seminal fluid surrogates using novel concentration-distance parameters that could be repeated over time. These methods are needed to develop rationally rectal microbicides to target and prevent HIV infection. METHODS Eight subjects were dosed rectally with radiolabelled and gadolinium-labelled gels to simulate microbicide gel and seminal fluid. Rectal doses were given with and without simulated receptive anal intercourse. Twenty-four hour distribution was assessed with indirect single photon emission computed tomography (SPECT)/computed tomography (CT) and magnetic resonance imaging (MRI), and direct assessment via sigmoidoscopic brushes. Concentration-distance curves were generated using an algorithm for fitting SPECT data in three dimensions. Three novel concentration-distance parameters were defined to describe quantitatively the distribution of radiolabels: maximal distance (Dmax), distance at maximal concentration (DCmax) and mean residence distance (Dave). RESULTS The SPECT/CT distribution of microbicide and semen surrogates was similar. Between 1h and 24h post dose, the surrogates migrated retrograde in all three parameters (relative to coccygeal level; geometric mean [95% confidence interval]): maximal distance (Dmax), 10cm (8.6-12) to 18cm (13-26), distance at maximal concentration (DCmax), 3.8cm (2.7-5.3) to 4.2cm (2.8-6.3) and mean residence distance (Dave), 4.3cm (3.5-5.1) to 7.6cm (5.3-11). Sigmoidoscopy and MRI correlated only roughly with SPECT/CT. CONCLUSIONS Rectal microbicide surrogates migrated retrograde during the 24h following dosing. Spatial kinetic parameters estimated using three dimensional curve fitting of distribution data should prove useful for evaluating rectal formulations of drugs for HIV prevention and other indications.Original Abstract: WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Rectally applied drugs have been imaged using radioisotopes and magnetic resonance contrast agents. However, prior studies have not described the distribution and clearance of rectally‐applied drugs in quantitative terms with respect to complex three dimensional paths through the gastrointestinal tract. Such tools would allow statistical comparisons of candidate products in development or comparison of drug product with the distribution of a drug target, for example, HIV infected seminal fluid. WHAT THIS STUDY ADDS • New quantitative spatial parameters, derived from three dimensional curve fitting, have been successfully applied in this study to quantify the distribution of rectally‐applied gels. Indirect assessment using nuclear medicine techniques avoided the distortion and redistribution associated with sigmoidoscopic sampling. Thus, these measurements can be repeated over time to create concentration–distance–time surfaces to describe rectal product distribution and clearance within the gastrointestinal lumen to inform microbicide and other rectal product development. AIMS We sought to describe quantitatively the distribution of rectally administered gels and seminal fluid surrogates using novel concentration–distance parameters that could be repeated over time. These methods are needed to develop rationally rectal microbicides to target and prevent HIV infection. METHODS Eight subjects were dosed rectally with radiolabelled and gadolinium‐labelled gels to simulate microbicide gel and seminal fluid. Rectal doses were given with and without simulated receptive anal intercourse. Twenty‐four hour distribution was assessed with indirect single photon emission computed tomography (SPECT)/computed tomography (CT) and magnetic resonance imaging (MRI), and direct assessment via sigmoidoscopic brushes. Concentration–distance curves were generated using an algorithm for fitting SPECT data in three dimensions. Three novel concentration–distance parameters were defined to describe quantitatively the distribution of radiolabels: maximal distance (Dmax), distance at maximal concentration (DCmax) and mean residence distance (Dave). RESULTS The SPECT/CT distribution of microbicide and semen surrogates was similar. Between 1 h and 24 h post dose, the surrogates migrated retrograde in all three parameters (relative to coccygeal level; geometric mean [95% confidence interval]): maximal distance (Dmax), 10 cm (8.6–12) to 18 cm (13–26), distance at maximal concentration (DCmax), 3.8 cm (2.7–5.3) to 4.2 cm (2.8–6.3) and mean residence distance (Dave), 4.3 cm (3.5–5.1) to 7.6 cm (5.3–11). Sigmoidoscopy and MRI correlated only roughly with SPECT/CT. CONCLUSIONS Rectal microbicide surrogates migrated retrograde during the 24 h following dosing. Spatial kinetic parameters estimated using three dimensional curve fitting of distribution data should prove useful for evaluating rectal formulations of drugs for HIV prevention and other indications.
We sought to describe quantitatively the distribution of rectally administered gels and seminal fluid surrogates using novel concentration-distance parameters that could be repeated over time. These methods are needed to develop rationally rectal microbicides to target and prevent HIV infection. Eight subjects were dosed rectally with radiolabelled and gadolinium-labelled gels to simulate microbicide gel and seminal fluid. Rectal doses were given with and without simulated receptive anal intercourse. Twenty-four hour distribution was assessed with indirect single photon emission computed tomography (SPECT)/computed tomography (CT) and magnetic resonance imaging (MRI), and direct assessment via sigmoidoscopic brushes. Concentration-distance curves were generated using an algorithm for fitting SPECT data in three dimensions. Three novel concentration-distance parameters were defined to describe quantitatively the distribution of radiolabels: maximal distance (D(max) ), distance at maximal concentration (D(Cmax) ) and mean residence distance (D(ave) ). The SPECT/CT distribution of microbicide and semen surrogates was similar. Between 1 h and 24 h post dose, the surrogates migrated retrograde in all three parameters (relative to coccygeal level; geometric mean [95% confidence interval]): maximal distance (D(max) ), 10 cm (8.6-12) to 18 cm (13-26), distance at maximal concentration (D(Cmax) ), 3.8 cm (2.7-5.3) to 4.2 cm (2.8-6.3) and mean residence distance (D(ave) ), 4.3 cm (3.5-5.1) to 7.6 cm (5.3-11). Sigmoidoscopy and MRI correlated only roughly with SPECT/CT. Rectal microbicide surrogates migrated retrograde during the 24 h following dosing. Spatial kinetic parameters estimated using three dimensional curve fitting of distribution data should prove useful for evaluating rectal formulations of drugs for HIV prevention and other indications.
Author Bakshi, Rahul P.
Lee, Linda A.
Macura, Katarzyna
Khan, Wasif A.
Caffo, Brian S.
Li, Liye
Cao, Ying J.
Fuchs, Edward J.
Wahl, Richard L.
Du, Yong
Grohskopf, Lisa A.
Hendrix, Craig W.
Author_xml – sequence: 1
  givenname: Ying J.
  surname: Cao
  fullname: Cao, Ying J.
– sequence: 2
  givenname: Brian S.
  surname: Caffo
  fullname: Caffo, Brian S.
– sequence: 3
  givenname: Edward J.
  surname: Fuchs
  fullname: Fuchs, Edward J.
– sequence: 4
  givenname: Linda A.
  surname: Lee
  fullname: Lee, Linda A.
– sequence: 5
  givenname: Yong
  surname: Du
  fullname: Du, Yong
– sequence: 6
  givenname: Liye
  surname: Li
  fullname: Li, Liye
– sequence: 7
  givenname: Rahul P.
  surname: Bakshi
  fullname: Bakshi, Rahul P.
– sequence: 8
  givenname: Katarzyna
  surname: Macura
  fullname: Macura, Katarzyna
– sequence: 9
  givenname: Wasif A.
  surname: Khan
  fullname: Khan, Wasif A.
– sequence: 10
  givenname: Richard L.
  surname: Wahl
  fullname: Wahl, Richard L.
– sequence: 11
  givenname: Lisa A.
  surname: Grohskopf
  fullname: Grohskopf, Lisa A.
– sequence: 12
  givenname: Craig W.
  surname: Hendrix
  fullname: Hendrix, Craig W.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22404308$$D View this record in MEDLINE/PubMed
BookMark eNqNUstuEzEUtVARTQu_gLxkk8GP8TwWIEFUaKVKFFHWlsf2JI489mB7aPMjfC-epA2wot74cc49917fcwZOnHcaAIhRgfN6uy0wrdiSYMIKgjApUEmqurh_BhZH4AQsEEXVkhGGT8FZjFuEMMUVewFOCSlRSVGzAL--TsIl0xspkvEO-h6mjYZxzFdhoTIxBdNNj1jQMglrd1CMozVawTiF4Nci6Qh7H-BgZPCdkUZpKFyG9aAdNA5Kb7PCnUkb-O3mYnW7RwexdjoZmWWjd8JJDU1-M279EjzvhY361cN-Dr5_urhdXS6vv3y-Wn24XkqG6nqpVNt1jHaE9F1fV5pUom2oRC2u67amtCp7UinClKirmjUYl7JTomslEZWQqqHn4P1Bd5y6QSupXQrC8jHkOsKOe2H4v4gzG772PzllhDSYZYE3DwLB_5h0THwwUWprhdN-ihzntIS2ZYv_T8UMt3lyJcrU13-XdazncW6Z0BwI-btjDLo_UjDis0X4ls9O4LMT-GwRvrcIv__T8jFUmrQffm7Q2KcIvDsI3Bmrd09OzD-ubuYT_Q36NNhk
CitedBy_id crossref_primary_10_1089_aid_2016_0167
crossref_primary_10_1111_bcp_12030
crossref_primary_10_1089_aid_2013_0189
crossref_primary_10_1002_cpt_1227
crossref_primary_10_1016_j_addr_2016_01_017
crossref_primary_10_1089_aid_2016_0318
crossref_primary_10_4049_jimmunol_2000320
crossref_primary_10_4155_tde_2017_0056
crossref_primary_10_1089_aid_2015_0086
crossref_primary_10_1089_aid_2015_0054
crossref_primary_10_1089_aid_2015_0098
crossref_primary_10_1016_j_jconrel_2015_08_042
crossref_primary_10_1016_j_jconrel_2014_09_013
crossref_primary_10_1517_17425247_2013_860132
crossref_primary_10_1097_QAI_0000000000003401
crossref_primary_10_1371_journal_pone_0167696
crossref_primary_10_1016_j_antiviral_2013_09_023
Cites_doi 10.1007/s10461-011-9899-9
10.1097/01.aids.0000216374.61442.55
10.1198/016214508000000832
10.1023/A:1001918504344
10.1093/infdis/jir841
10.1118/1.2768863
10.1097/00002030-200103090-00017
10.1002/cpt1979253358
10.1097/QAI.0b013e3182373b5e
10.1038/sj.clpt.6100236
10.1126/science.1193748
ContentType Journal Article
Copyright 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society
2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.
Copyright © 2012 The British Pharmacological Society 2012
Copyright_xml – notice: 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society
– notice: 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.
– notice: Copyright © 2012 The British Pharmacological Society 2012
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T7
8FD
C1K
FR3
P64
5PM
DOI 10.1111/j.1365-2125.2012.04267.x
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Industrial and Applied Microbiology Abstracts (Microbiology A)
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Engineering Research Database
Technology Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList CrossRef
MEDLINE - Academic
Engineering Research Database

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1365-2125
EndPage 1022
ExternalDocumentID PMC3522815
22404308
10_1111_j_1365_2125_2012_04267_x
BCP4267
Genre article
Research Support, U.S. Gov't, P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCRR NIH HHS
  grantid: UL1 RR 025005
– fundername: NIAID NIH HHS
  grantid: K24 AI001825
– fundername: PHS HHS
  grantid: 200-2001-08015
– fundername: NCRR NIH HHS
  grantid: UL1 RR025005
– fundername: NIAID NIH HHS
  grantid: K24 AI 01825
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OC
23N
24P
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AOIJS
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FIJ
FUBAC
G-S
G.N
GODZA
GX1
H.X
HF~
HGLYW
HYE
HZI
HZ~
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
ROL
RPM
RX1
SUPJJ
TEORI
TR2
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
7T7
8FD
C1K
FR3
P64
5PM
ID FETCH-LOGICAL-c5077-dd9bb53b22fbf76e26a983c09177973364f26d25da76758114cbdab9c2a6acd83
IEDL.DBID DR2
ISSN 0306-5251
1365-2125
IngestDate Thu Aug 21 18:02:04 EDT 2025
Fri Jul 11 16:14:05 EDT 2025
Fri Jul 11 04:27:31 EDT 2025
Wed Feb 19 02:08:04 EST 2025
Tue Jul 01 02:29:34 EDT 2025
Thu Apr 24 22:50:43 EDT 2025
Wed Jan 22 16:20:31 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5077-dd9bb53b22fbf76e26a983c09177973364f26d25da76758114cbdab9c2a6acd83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2125.2012.04267.x
PMID 22404308
PQID 1151921240
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3522815
proquest_miscellaneous_1758239491
proquest_miscellaneous_1151921240
pubmed_primary_22404308
crossref_primary_10_1111_j_1365_2125_2012_04267_x
crossref_citationtrail_10_1111_j_1365_2125_2012_04267_x
wiley_primary_10_1111_j_1365_2125_2012_04267_x_BCP4267
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2012
PublicationDateYYYYMMDD 2012-12-01
PublicationDate_xml – month: 12
  year: 2012
  text: December 2012
PublicationDecade 2010
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: England
PublicationTitle British journal of clinical pharmacology
PublicationTitleAlternate Br J Clin Pharmacol
PublicationYear 2012
Publisher Blackwell Publishing Ltd
Blackwell Science Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Blackwell Science Inc
References 2000; 29
2006; 20
2010; 329
1979; 25
2011
2011; 60
2008; 49
2001; 15
2011; 15
2008; 103
2012; 59
2008; 83
1996; 2
2007; 34
2012; 205
1995; 7
e_1_2_7_5_2
Frey EC (e_1_2_7_14_2) 1996; 2
e_1_2_7_3_2
e_1_2_7_2_2
e_1_2_7_9_2
e_1_2_7_7_2
e_1_2_7_6_2
e_1_2_7_19_2
e_1_2_7_18_2
e_1_2_7_17_2
Erickson PI (e_1_2_7_8_2) 1995; 7
e_1_2_7_16_2
e_1_2_7_13_2
e_1_2_7_11_2
e_1_2_7_10_2
Centers for Disease Control and Prevention (e_1_2_7_4_2) 2011; 60
Development Core Team (e_1_2_7_12_2) 2011
Du Y (e_1_2_7_15_2) 2008; 49
References_xml – year: 2011
– volume: 34
  start-page: 3530
  year: 2007
  end-page: 43
  article-title: Model‐based crosstalk compensation for simultaneous 99mTc/123I dual‐isotope brain SPECT imaging
  publication-title: Med Phys
– volume: 205
  start-page: 725
  year: 2012
  end-page: 32
  article-title: Distribution of cell‐free and cell‐associated HIV surrogates in the female genital tract following simulated vaginal intercourse
  publication-title: J Infect Dis
– volume: 29
  start-page: 357
  year: 2000
  end-page: 73
  article-title: Heterosexual anal intercourse: an understudied, high‐risk sexual behavior
  publication-title: Arch Sex Behav
– volume: 7
  start-page: 477
  year: 1995
  end-page: 93
  article-title: Prevalence of anal sex among heterosexuals in California and its relationship to other AIDS risk behaviors
  publication-title: AIDS Educ Prev
– volume: 2
  start-page: 1082
  year: 1996
  end-page: 86
  article-title: A new method for modeling the spatially‐variant, object‐dependent scatter response function in SPECT
  publication-title: IEEE NUCL SCI SYMP
– volume: 59
  start-page: 10
  year: 2012
  end-page: 7
  article-title: Distribution of cell‐free and cell‐associated HIV surrogates in the colon following simulated receptive anal intercourse in men
  publication-title: J Acquir Immune Defic Syndr
– volume: 25
  start-page: 358
  year: 1979
  end-page: 71
  article-title: Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d‐tubocurarine
  publication-title: Clin Pharmacol Ther
– volume: 20
  start-page: 731
  year: 2006
  end-page: 9
  article-title: Risk factors for HIV infection among men who have sex with men
  publication-title: AIDS
– volume: 49
  start-page: 152P
  year: 2008
  article-title: Model‐based downscatter compensation for simultaneous Tc‐99m/In‐111 dual‐isotope SPECT imaging. 2008 SNM Annual Meeting, June, New Orleans, LA
  publication-title: J Nucl Med
– volume: 83
  start-page: 97
  year: 2008
  end-page: 105
  article-title: Quantitative imaging and sigmoidoscopy to assess distribution of rectal microbicide surrogates
  publication-title: Clin Pharmacol Ther
– volume: 329
  start-page: 1168
  year: 2010
  end-page: 74
  article-title: Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women
  publication-title: Science
– volume: 60
  start-page: 87
  year: 2011
  end-page: 9
  article-title: HIV Infection – United States, 2005 and 2008
  publication-title: MMWR Surveill Summ
– volume: 15
  start-page: 534
  year: 2001
  end-page: 5
  article-title: Anal intercourse among young low‐income women in California: an overlooked risk factor for HIV?
  publication-title: AIDS
– volume: 15
  start-page: S66
  issue: 1
  year: 2011
  end-page: 71
  article-title: Rectal microbicides: can we make them and will people use them?
  publication-title: AIDS Behav
– volume: 103
  start-page: 1470
  year: 2008
  end-page: 80
  article-title: A case study in pharmacologic colon imaging using principal curves in single photon emission computed tomography
  publication-title: J Am Stat Assoc
– volume: 7
  start-page: 477
  year: 1995
  ident: e_1_2_7_8_2
  article-title: Prevalence of anal sex among heterosexuals in California and its relationship to other AIDS risk behaviors
  publication-title: AIDS Educ Prev
– ident: e_1_2_7_9_2
  doi: 10.1007/s10461-011-9899-9
– ident: e_1_2_7_5_2
  doi: 10.1097/01.aids.0000216374.61442.55
– ident: e_1_2_7_16_2
  doi: 10.1198/016214508000000832
– ident: e_1_2_7_3_2
– ident: e_1_2_7_7_2
  doi: 10.1023/A:1001918504344
– ident: e_1_2_7_11_2
– ident: e_1_2_7_18_2
  doi: 10.1093/infdis/jir841
– ident: e_1_2_7_13_2
  doi: 10.1118/1.2768863
– volume: 2
  start-page: 1082
  year: 1996
  ident: e_1_2_7_14_2
  article-title: A new method for modeling the spatially‐variant, object‐dependent scatter response function in SPECT
  publication-title: IEEE NUCL SCI SYMP
– ident: e_1_2_7_6_2
  doi: 10.1097/00002030-200103090-00017
– ident: e_1_2_7_19_2
  doi: 10.1002/cpt1979253358
– ident: e_1_2_7_17_2
  doi: 10.1097/QAI.0b013e3182373b5e
– ident: e_1_2_7_10_2
  doi: 10.1038/sj.clpt.6100236
– volume: 60
  start-page: 87
  year: 2011
  ident: e_1_2_7_4_2
  article-title: HIV Infection – United States, 2005 and 2008
  publication-title: MMWR Surveill Summ
– volume-title: A Language and Environment for Statistical Computing
  year: 2011
  ident: e_1_2_7_12_2
– volume: 49
  start-page: 152P
  year: 2008
  ident: e_1_2_7_15_2
  article-title: Model‐based downscatter compensation for simultaneous Tc‐99m/In‐111 dual‐isotope SPECT imaging. 2008 SNM Annual Meeting, June, New Orleans, LA
  publication-title: J Nucl Med
– ident: e_1_2_7_2_2
  doi: 10.1126/science.1193748
SSID ssj0013165
Score 2.1512628
Snippet WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Rectally applied drugs have been imaged using radioisotopes and magnetic resonance contrast agents. However, prior...
We sought to describe quantitatively the distribution of rectally administered gels and seminal fluid surrogates using novel concentration-distance parameters...
times Rectally applied drugs have been imaged using radioisotopes and magnetic resonance contrast agents. However, prior studies have not described the...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1013
SubjectTerms Administration, Rectal
Adult
Anti-Infective Agents - pharmacokinetics
Cellulose - analogs & derivatives
Cellulose - pharmacokinetics
Colon - metabolism
Gadolinium - pharmacokinetics
Gadolinium DTPA - pharmacokinetics
gastrointestinal distribution
Glycerol - pharmacokinetics
HIV Infections - prevention & control
HIV microbicide
HIV prevention
Homosexuality, Male
Human immunodeficiency virus
Humans
Magnetic Resonance Imaging - methods
Male
Methods in Clinical Pharmacology
Middle Aged
Models, Theoretical
Pentetic Acid - pharmacokinetics
pharmacokinetics
Phosphates - pharmacokinetics
Propylene Glycols - pharmacokinetics
rectal dosing
Semen - physiology
Sigmoidoscopy - methods
Technetium Tc 99m Sulfur Colloid - pharmacokinetics
Tomography, Emission-Computed, Single-Photon - methods
Title Quantification of the spatial distribution of rectally applied surrogates for microbicide and semen in colon with SPECT and magnetic resonance imaging
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1365-2125.2012.04267.x
https://www.ncbi.nlm.nih.gov/pubmed/22404308
https://www.proquest.com/docview/1151921240
https://www.proquest.com/docview/1758239491
https://pubmed.ncbi.nlm.nih.gov/PMC3522815
Volume 74
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfQnngBxmdhTEZCe1qqOh9O_AjVpgECFeikvUX-CkRrXdQ0EuUP4e_lzk7bhSE0Id6iXGzr5Dv7d875d4S85EqwSnMTMZPYKE3MKCq4HUU5VnphesSkr3X4_gM_O0_fXmQXXf4T3oUJ_BDbAzf0DL9eo4NL1fSd3GdowQ6NGVrxEKOBfIh4EgWIjz7Fux8KzFeVRIQMsVfG-kk9f-yov1Ndg5_Xsyivolu_PZ3eJZcbxUJWyuWwXamh_vEb5-P_0fweudOhWPoqmN0-uWXdfXI0CTTY62M63d3qao7pEZ3sCLLXD8jPj60MOUreLOiiogBDaYPJ3dCrQS7frgwXynBNlrPZmsqAmGnTLpcLPP5rKEBuOq89mZSujaXSgRhPPGntKI7nKJ4008-Tk_HUS-fyi8OLm9AtRiFg87Se-1JND8n56cl0fBZ19SEiDSg2j4wRSmWJiuNKVTm3MZeiSDQgoDwXSPOYVjE3cWYkMtYUEPlpZaQSOpZcalMkj8ieWzj7hFAIG6usEkIXAMhSrlUBYVmqhEgzra2xA5JvbKHUHXk61vCYlVeCKJiUEielxEkp_aSU3weEbVt-CwQiN2jzYmNuJXg7_sKRzi7aBpplSGAHMOwv34CuWPBesAF5HEx0OzICuDQZFaBPz3i3HyDbeF_i6q-edRyResGyAeHeNm-sTPl6PMGnp__a8Bm5ja9DDtEB2VstW_sckOBKHYKPv3l36D39F71JUw4
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Zb9NAEF6h8gAv3EfKtUioT3UUX2vvI0StArRVgFTq22ovF4tkU8WxRPgh_F5m1k5SU4QqxJulPazVzni_Gc9-HyFvmOJhoZkJQhPbIInNIMiZHQQZKr2EehBKr3V4fMJGp8mHs_SslQPCuzANP8Qm4Yae4b_X6OCYkO56uS_RgiMaS7SiPoYDWR8A5U0U-Pbx1edo-0sh9LqSiJEh-krDblnPH2fqnlVXAOjVOsrL-NYfUId3yXS9tKYu5Vu_Xqq-_vEb6-N_Wvs9cqcFsvRtY3n3yQ3rHpC9ccOEvdqnk-3Frmqf7tHxliN79ZD8_FTLpkzJWwadFxSQKK2wvhtmNUjn2ypxYRt-luV0uqKyAc20qheLOWYAKwqom85KzyelS2OpdNCMSU9aOorvcxSTzfTL-GA48a0zee7w7iZMi4EImD0tZ16t6RE5PTyYDEdBKxERaACyWWAMVyqNVRQVqsiYjZjkeawBBGUZR6bHpIiYiVIjkbQmh-BPKyMV15FkUps8fkx23NzZp4RC5FikBec6B0yWMK1yiMwSxXmSam2N7ZFsbQxCt_zpKOMxFZfiKNgUgZsicFOE3xTxvUfCzciLhkPkGmNer-1NgMPjXxzp7LyuYFiKHHaAxP7SB9aKmvc87JEnjY1u3owYLokHOaynY72bDkg43m1x5VdPPI5gPQ_THmHeOK-9GPFuOMan3X8d-IrcGk2Oj8TR-5OPz8ht7NKUFD0nO8tFbV8AMFyql97hfwHO6VYw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Zb9NAEF6hIiFeuKHhXCTUpzry-lh7HyFtVK7KQCr1zdrLYDVxqjiWCD-E38vM2klqilCFeLO0hzXab7zfrGe_IeQVV4IVmhuPmdB6UWh8L-XW9xKs9MK0z6SrdfjxmB-dRO9O49Mu_wnvwrT6EJsDN_QM971GBz83Rd_JXYYW7NCYoRUMMRpIhsAnr0fcTxHhB5-D7R8F5spKIkWG4Ctm_ayeP87U36ou8c_LaZQX6a3bn8a3ydnasjYt5WzYLNVQ__hN9PH_mH6H3OpoLH3d4u4uuWare2Qva3WwV_t0sr3WVe_TPZptFbJX98nPT41sk5QcLui8oMBDaY3Z3TCrQTHfrg4XtuFHWU6nKypbykzrZrGY4_lfTYFz01np1KR0aSyVFTTjkSctK4rvqygeNdMv2eFo4lpn8muFNzdhWgxDAPS0nLlaTQ_IyfhwMjryugIRngYam3jGCKXiUAVBoYqE24BLkYYaKFCSCNR5jIqAmyA2EiVrUgj9tDJSCR1ILrVJw4dkp5pXdpdQiBuLuBBCp8DIIq5VCnFZpISIYq2tsQOSrLGQ6049HYt4TPMLURQsSo6LkuOi5G5R8u8DwjYjz1sFkSuMebmGWw7ujv9wZGXnTQ3DYlSwAx72lz5gK1a8F2xAHrUQ3bwZGVwU-inY0wPvpgPKjfdbqvKbkx1Hqp6yeEC4w-aVjcnfjDJ8evyvA1-QG9nBOP_w9vj9E3ITe7T5RE_JznLR2GfACpfquXP3X6EIVOg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantification+of+the+spatial+distribution+of+rectally+applied+surrogates+for+microbicide+and+semen+in+colon+with+SPECT+and+magnetic+resonance+imaging&rft.jtitle=British+journal+of+clinical+pharmacology&rft.au=Cao%2C+Ying+J.&rft.au=Caffo%2C+Brian+S.&rft.au=Fuchs%2C+Edward+J.&rft.au=Lee%2C+Linda+A.&rft.date=2012-12-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=0306-5251&rft.eissn=1365-2125&rft.volume=74&rft.issue=6&rft.spage=1013&rft.epage=1022&rft_id=info:doi/10.1111%2Fj.1365-2125.2012.04267.x&rft.externalDBID=10.1111%252Fj.1365-2125.2012.04267.x&rft.externalDocID=BCP4267
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0306-5251&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0306-5251&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0306-5251&client=summon